glp-1 news today october 23 2025 FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of How to Survive the GLP-1

In a head-to-head trial, tirzepatide users lost about 20% of body weight versus roughly 15% with semaglutide over 72 weeks

Their multifaceted roles in metabolic reprogramming, stress responses, signal transduction, and intercellular communication establish them as critical modulators in tumor biology and primary intervention targets

Talk to your healthcare provider about these Zepbound and Mounjaro alternatives if your Aetna plan does not cover tirzepatide

However, its incidence has gradually increased and is expected to reach the levels observed in Western countries

Plaintiffs with objective medical testing, prolonged treatment, permanent impairment, or emergency medical intervention may also present stronger claims during settlement negotiations or trial proceedings